{"id":2742,"date":"2015-04-15T14:29:39","date_gmt":"2015-04-15T12:29:39","guid":{"rendered":"https:\/\/www.farmaindustria.es\/web_en\/?p=2742"},"modified":"2015-04-16T09:53:41","modified_gmt":"2015-04-16T07:53:41","slug":"sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5","status":"publish","type":"post","link":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/","title":{"rendered":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5%"},"content":{"rendered":"<p><strong>Madrid, April 14th 2015.<\/strong>&#8211; The market of prescription medicines (basically comprised by branded medicines, with or without patent protection) dropped in Spain by 1.4% in 2014, while sales of generic medicines in the same period experienced a growth of 9.5%; this is reflected in <a href=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/2Bolet%C3%ADn-Coyuntura-n118-Ingl%C3%A9s-febrero-2015.pdf\">Farmaindustria\u2019s Monthly Economic Bulletin n\u00ba 118<\/a>.<\/p>\n<p><a href=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter  wp-image-2743\" src=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\" alt=\"Sales of branded medicines\" width=\"515\" height=\"288\" srcset=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg 706w, https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines-300x168.jpg 300w, https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines-50x28.jpg 50w\" sizes=\"auto, (max-width: 515px) 100vw, 515px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>The figures demonstrate the duality in which the Spanish pharmaceutical market in immersed, both in the public and private environments, with important growth as far as the sales of generics medicines is concerned, and strong reductions in the sales of medicines still under patent protection. This situation, which has lead the general trend during the last year won\u2019t be experiencing significant changes in 2015, as it has already been foreseen by the main analysts of the sector.<\/p>\n<p><strong>The generic priced market already represents almost 80% of the total of prescriptions<\/strong><\/p>\n<p>As reflected in the Bulletin, the generic priced market represents almost 80% of the prescription market in Spain (78.3%) and 47.9% of said market in values, experiencing a steep growth during recent years. Only two years before, in 2012, the market share of generic priced medicines was 67.1% in units and 39.6% in values, which implies a growth of the market share of these medicines of 17% in units and 21% in values in a two years period.<\/p>\n<p>On the other hand, the Bulletin analyzes the regional pharmaceutical market during the last term, stating the great dispersion of per capita public pharmaceutical expenditure in Spain, which ranges from 268\u20ac per citizen in Extremadura to 163 in the Balearic Islands, not taking into account the autonomous cities of Ceuta and Melilla. This dispersion has been reduced in Spain during the last year, considering the variation coefficient has passed from 13.2% in 2013 to 12.7% in 2014.<\/p>\n<p>According to available data, one of the most important variables which causes the great differences between Spanish regions, both in terms of public pharmaceutical expenditure per capita as in terms of prescriptions consumption per capita is the diverse degree of ageing of its population.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Madrid, April 14th 2015.&#8211; The market of prescription medicines (basically comprised by branded medicines, with or without patent protection) dropped in Spain by 1.4% in 2014, while sales of generic medicines in the same period experienced a growth of 9.5%; this is reflected in Farmaindustria\u2019s Monthly Economic Bulletin n\u00ba 118. &nbsp; &nbsp; The figures demonstrate  <a href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\" class=\"read-more\">&hellip;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2742","post","type-post","status-publish","format-standard","hentry","tema-medicamentos-genericos","tema-gasto-sanitario","tema-gasto-farmaceutico","tema-regions"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria\" \/>\n<meta property=\"og:description\" content=\"Madrid, April 14th 2015.&#8211; The market of prescription medicines (basically comprised by branded medicines, with or without patent protection) dropped in Spain by 1.4% in 2014, while sales of generic medicines in the same period experienced a growth of 9.5%; this is reflected in Farmaindustria\u2019s Monthly Economic Bulletin n\u00ba 118. &nbsp; &nbsp; The figures demonstrate &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\" \/>\n<meta property=\"og:site_name\" content=\"FarmaIndustria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-15T12:29:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-04-16T07:53:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\" \/>\n<meta name=\"author\" content=\"Nathalie Rooney\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:site\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nathalie Rooney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\"},\"author\":{\"name\":\"Nathalie Rooney\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"headline\":\"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5%\",\"datePublished\":\"2015-04-15T12:29:39+00:00\",\"dateModified\":\"2015-04-16T07:53:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\"},\"wordCount\":336,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\",\"name\":\"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\",\"datePublished\":\"2015-04-15T12:29:39+00:00\",\"dateModified\":\"2015-04-16T07:53:41+00:00\",\"author\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\",\"contentUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg\",\"width\":706,\"height\":395},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.farmaindustria.es\/web_en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/\",\"name\":\"FarmaIndustria\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\",\"name\":\"Nathalie Rooney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"caption\":\"Nathalie Rooney\"},\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/","og_locale":"en_US","og_type":"article","og_title":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria","og_description":"Madrid, April 14th 2015.&#8211; The market of prescription medicines (basically comprised by branded medicines, with or without patent protection) dropped in Spain by 1.4% in 2014, while sales of generic medicines in the same period experienced a growth of 9.5%; this is reflected in Farmaindustria\u2019s Monthly Economic Bulletin n\u00ba 118. &nbsp; &nbsp; The figures demonstrate &hellip;","og_url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/","og_site_name":"FarmaIndustria","article_publisher":"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl","article_published_time":"2015-04-15T12:29:39+00:00","article_modified_time":"2015-04-16T07:53:41+00:00","og_image":[{"url":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg","type":"","width":"","height":""}],"author":"Nathalie Rooney","twitter_card":"summary_large_image","twitter_creator":"@FarmaIndustria","twitter_site":"@FarmaIndustria","twitter_misc":{"Written by":"Nathalie Rooney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#article","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/"},"author":{"name":"Nathalie Rooney","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"headline":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5%","datePublished":"2015-04-15T12:29:39+00:00","dateModified":"2015-04-16T07:53:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/"},"wordCount":336,"commentCount":0,"image":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/","url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/","name":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5% - FarmaIndustria","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage"},"image":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg","datePublished":"2015-04-15T12:29:39+00:00","dateModified":"2015-04-16T07:53:41+00:00","author":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"breadcrumb":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#primaryimage","url":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg","contentUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/04\/Sales-of-branded-medicines.jpg","width":706,"height":395},{"@type":"BreadcrumbList","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/04\/15\/sales-branded-medicines-decreased-1-4-2014-whereas-generic-market-grew-9-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.farmaindustria.es\/web_en\/"},{"@type":"ListItem","position":2,"name":"Sales of branded medicines decreased by 1.4% in 2014, whereas the generic market grew by 9.5%"}]},{"@type":"WebSite","@id":"https:\/\/www.farmaindustria.es\/web_en\/#website","url":"https:\/\/www.farmaindustria.es\/web_en\/","name":"FarmaIndustria","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603","name":"Nathalie Rooney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","caption":"Nathalie Rooney"},"url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/"}]}},"_links":{"self":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/comments?post=2742"}],"version-history":[{"count":2,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2742\/revisions"}],"predecessor-version":[{"id":2747,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2742\/revisions\/2747"}],"wp:attachment":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/media?parent=2742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}